J Menopausal Med.  2014 Apr;20(1):7-13.

Awareness and Experience of Menopausal Symptom and Hormone Therapy in Korean Postmenopausal Women

Affiliations
  • 1Department of Obstetrics and Gynecology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
  • 2Department of Obstetrics and Gynecology, Ewha Womans University, School of Medicine, Seoul, Korea.
  • 3Department of Obstetrics and Gynecology, Soonchunhyang University, College of Meidicine, Seoul, Korea.
  • 4Department of Obstetrics and Gynecology, Chung-Ang University Hospital, College of Medicine, Seoul, Korea. hmpark52@hanmail.net

Abstract


OBJECTIVES
To investigate awareness and experience of menopausal symptom and hormone therapy in Korean postmenopausal women.
METHODS
A total of 570 postmenopausal women were accepted our survey. The women filled out the questionnaires composed of medical and surgical history, menopausal age and symptom, demand of treatment on menopausal symptom, and personal method for overcoming the symptom. Also, we make inquiries about experience of hormone therapy, concern about hormone therapy, improvement of menopausal symptom after therapy, adverse effect, and cause of cease the therapy.
RESULTS
According to the survey, 80% (456/570) of the women experienced menopausal symptom. When they felt the symptom at first, 47% (213/570) of women was 46-50 years old. The most common menopausal symptom was hot flushes (141/570). A number of Korean women regarded that menopause was a natural process of ageing (69%). Eighty two % of women thought to need to have treatment on menopausal symptom. However, only half (43%) visited doctor. The most concerned disease after menopause they had answered was osteoporosis (60%) but only 22% of women were taken regular check-up of bone mineral density. The common causes were unwilling to do treatment were concern about adverse effect (51%) and indefinite fear of cancer (32%). Moreover, many women got diverse information about menopause from the mass media than professional advice.
CONCLUSION
Only a minority of Korean postmenopausal women with menopausal symptoms had taken a hormone therapy. We should provide appropriate education and counsel to Korean peri-menopause women.

Keyword

Awareness; Experience; Hormone therapy; Korean postmenopausal women; Menopausal symptom

MeSH Terms

Bone Density
Education
Female
Humans
Mass Media
Menopause
Osteoporosis
Surveys and Questionnaires

Figure

  • Fig. 1 Age of menopause.

  • Fig. 2 Age of menopausal symptom.

  • Fig. 3 Proportions of bone mineral density check after menopause.

  • Fig. 4 Proportions of mammography check after menopause.

  • Fig. 5 Experiences of hormone therapy.

  • Fig. 6 Motivation of hormone therapy.

  • Fig. 7 Experienced side effects during hormone therapy.


Reference

1. Choi H, Lee HK, Park HM. The Korean menopausal women`s attitudes and awareness on menopause: results of Korean gallup epidemiologic survey on menopause and HRT. J Korean Soc Menopause. 2003; 9:36–43.
2. Deeks A, Zoungas S, Teede H. Risk perception in women: a focus on menopause. Menopause. 2008; 15:304–309.
3. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002; 288:321–333.
4. Chung YJ, Kim MR, Jeong HW, Yoon BK, Lee BS, Kang BM, et al. Changing Korean Menopausal Women's Awareness on Hormone Therapy: 7-years after Women's Health Initiative Study. J Korean Soc Menopause. 2012; 18:94–99.
5. North American Menopause Society. Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause. 2010; 17:242–255.
6. Newton KM, Reed SD, Grothaus LC, La Croix AZ, Nekhlyudov L, Ehrlich K, et al. Hormone therapy discontinuation: physician practices after the Women's Health Initiative. Menopause. 2010; 17:734–740.
7. Phillips LS, Langer RD. Postmenopausal hormone therapy: critical reappraisal and a unified hypothesis. Fertil Steril. 2005; 83:558–566.
8. Sturdee DW, Pines A, Archer DF, Baber RJ, Barlow D, Birkhauser MH, et al. Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric. 2011; 14:302–320.
9. Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA. 2004; 291:47–53.
Full Text Links
  • JMM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr